Fact CheckerSign in

NCT04691297Active, not recruiting

Digitally Enhanced Smoking Cessation for High Risk Smokers

A Digitally-enhanced Smoking Cessation Intervention for High-risk Smokers: Phase II

Source: ClinicalTrials.gov · Last updated 19 Dec 2025

Brief summary (registry, in English)

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
153 (actual)
First submitted
17 Dec 2020
Start date
1 Feb 2021
Primary completion date
1 Feb 2023
Lead sponsor
Dana-Farber Cancer Institute
Diseases
Lung cancer
NCT number
NCT04691297

What you commit to

  • Study type: Interventional
  • Participants enrolled: 153
  • From 1 Feb 2021 to the primary completion date, 1 Feb 2023
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hospitalization for severe mental illness within the last year.

Other

  • The following special populations will not be included
    • Adults unable to consent
    • Individuals who are not yet adults (infants, children, teenagers)
    • Pregnant women
    • Prisoners

Who the study is looking for

  • 55 to 77 years of age
  • No previous history of lung cancer
  • ECOG performance status \< 2
  • ≥ 30 pack year smoking history
  • Smoke ≥ 5 cigarettes/day
  • Own a mobile phone with access to a video call application
  • Has a primary care provider (PCP)
  • Provide contact information for the PCP
  • Active health insurance
  • Has not had LDCT screening
  • English speaking
  • Can complete an interview

Age in the registry: 55 years to 77 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.